Let’s dig into the relative performance of Cigna (NYSE:CI) and its peers as we unravel the now-completed Q4 health insurance ...

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” fourth quarter 2024 ...

All but Cigna were among the portfolio's top-10 holdings ... We avoided these benchmark components in Q4, as we did not see compelling value opportunities among these names. Throughout the quarter ...

As the Q4 earnings season comes to a close ... which is why it's exciting to see The Cigna... TDOC expects revenues in the Integrated Care segment to witness 0-3% growth on a year-over-year ...

Q4 2024 Results Conference Call March 10, 2025 4:30 PM ETCompany ParticipantsJustin Schreiber - Chairman and Chief ...

Cigna reported fourth-quarter 2024 adjusted earnings per share of $6.64, which missed the Zacks Consensus Estimate by 15.2% due to a decline in its overall medical customer base and elevated ...

Newron Pharmaceuticals S.p.A. ("Newron") (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for diseases of the central and peripheral nervous system, ...

Twist Bioscience Corporation , a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that, for a limited time, all Twist Express Genes ...

We recently compiled a list of the Top 10 Health Insurance Stocks To Buy. In this article, we are going to take a look at ...

Wrapping up Q4 earnings, we look at the numbers and key ... Serving both corporate clients and individual customers, Cigna (NYSE:CI) offers health insurance and pharmacy benefit management ...

The health insurance market is projected to hit $4.45 trillion by 2032, growing at 9.7% annually. AI is playing a larger role ...